| Recruiting | 3 | 1700 | Europe, Canada, Japan, US, RoW | GSK3511294 (Depemokimab), Mepolizumab, Benralizumab, Placebo, Standard of care (SoC), Pre-filled Syringes (PFS) | GlaxoSmithKline, Iqvia Pty Ltd | Asthma | 09/25 | 09/25 | | |
TANGO, NCT06029595: Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy |
|
|
| Recruiting | 2 | 464 | Europe, RoW | Experimental: CHF6001 3200 μg, Placebo Comparator: CHF6001 Placebo | Chiesi Farmaceutici S.p.A. | Uncontrolled Asthma | 12/25 | 12/25 | | |